Mar 19, 2025 9:00 am EDT Case Study: bioAffinity Technologies’ Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence
Mar 13, 2025 9:00 am EDT Physicians’ Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung Cancer
Mar 6, 2025 8:00 am EST bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive CyPath® Lung Sales Growth
Feb 26, 2025 11:30 am EST bioAffinity Technologies Announces Closing of Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million
Feb 25, 2025 9:58 am EST bioAffinity Technologies Announces Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million
Jan 22, 2025 8:00 am EST bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic
Jan 13, 2025 8:00 am EST bioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® Lung
Dec 17, 2024 8:00 am EST Join bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19
Dec 5, 2024 8:00 am EST Veterans’ Research Foundation Spotlights CyPath® Lung’s Addition to the Federal Supply Schedule
